MedTrace Logo

Safety and Efficacy of P-ESWL and ERCP

NCT05916547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2071

Last updated 2024-07-11

No results posted yet for this study

Summary

To determine the types, incidence and risk factors of adverse events after pancreatic extracorporeal shock wave lithotripsy (P-ESWL) and endoscopic retrograde cholangiopancreatography (ERCP), define the grading criteria of adverse events after P-ESWL and ERCP, and analyze the efficacy of P-ESWL and ERCP, which will provide evidence-based medical evidence to guide physicians' clinical practice.

Conditions

  • Pancreatic Duct Stone

Interventions

PROCEDURE

pancreatic extracorporeal shock wave lithotripsy

Pancreatic extracorporeal shock wave lithotripsy is based on the principle of shock wave energy. Whenever energy is abruptly released in an enclosed space, shock waves are generated and then cross to the surface of pancreatic duct stones to cause further fragmentation.

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Liang-hao Hu, MD · Changhai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-04-26
Completion
2024-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05916547 on ClinicalTrials.gov